IVF is a process of fertilization where an egg is combined with sperm outside the body, in vitro in a liquid in a laboratory. Once the fertilized egg (zygote) undergoes embryo culture for 2–6 days, it is implanted in the same or another woman's uterus, with the intention of establishing a successful pregnancy. It is an assisted reproductive technology used for infertility treatment and gestational surrogacy.
In-Vitro Fertilization Market: Key Players
The research study includes profiles of leading companies operating in the global in-vitro fertilization market. Key players profiled in the report include: OvaScience, EMD Serono Inc., Vitrolife AB, Irvine Scientific, Cook Medical Inc., Cooper Surgical Inc., Genea Biomedx, Thermo Fisher Scientific Inc., Progyny, Inc., and Boston IVF.
The competition among the players is expected to get intense with the next few years with the growing focus of the players on the research and development activities with new launches.
Drivers for the Global In-Vitro Fertilization Market:
Increasing prevalence of infertility due to changing lifestyle and stressful life is the primary factor that has major impact on the growth of in-vitro fertilization market. Governments, across the globe, are making fervent efforts in creating awareness among people regarding IVF treatments. Increase in trend of delayed pregnancies leads to several problems which further enhances the growth of in-vitro fertilization.
Opportunities for the Global In-Vitro Fertilization Market:
The global in-vitro fertilization market is developing at a high pace with the technological advancements and the introduction of advanced treatments. The high awareness rate among people and the rising spending capacity of people, especially in emerging nations can create lucrative opportunities in near future. Increase in number of fertility clinics are further expected to propel the growth of in -vitro fertilization market.
Restrains for the Global In-Vitro Fertilization Market:
The low success rate and the high cost of IVF treatment and the reducing efficacy of the infertility treatment with the developing age are estimated to curb the growth of in-vitro fertilization. The cost of IVF treatment varies from country to country due to lack of reimbursement policies. Additionally, insurance companies do not generally cover the cost of infertility treatments.
Region Wise, Global In Vitro-Fertilization Market Analysis:
Asia Pacific region held maximum share in the growth of in-vitro fertilization market and is expected to propel high growth rate in coming years. This is due to rising infertility rates, growing prevalence of PCOS, increasing incidence of obesity, the rise in fertility tourism, and government initiatives. Europe is anticipated to be the second largest region in terms of market size in the IVF market. This can be attributed to the increasing obesity rates and PCOS, rising age of first-time pregnancy, declining birthrates, favorable regulatory amendments for IVF, and rise of IVF tourism.
Global In Vitro-Fertilization Market: Product analysis
- Imaging System
- Incubator
- Cabinets
- Sperm Separation System
- Cryopreservation media
- Embryo Culture media
Global In-Vitro Fertilization Market: Application analysis
- Fertility Clinics and Surgical Centers
- Cryobanks
Global In-Vitro Fertilization Market: Region analysis
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- France
- Germany
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- ASEAN
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Colombia
- Rest of L.A.
- Middle East and Africa
- Turkey
- GCC
- UAE
- South Africa
- Rest of Middle East
